1-9 of 9
Lars-Olof Mugge
Close
Sort by
Journal Articles

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Friederike Bachmann, MD, Swantje Held, Monika Engelhardt, MD, Christian Langer, MD, Denise Wolleschak, Janik Fleissner, Lars-Olof Mügge, MD, Heinz Duerk, MD PhD, Martin Schreder, MD, Kerstin Schaefer-Eckart, MD, Igor-Wolfgang Blau, MD PhD, Martin Gramatzki, MD, Peter Liebisch, MD, Albrecht Reichle, MD, Ivana Metzler, MD, Florian Bassermann, MD PhD, Bernd Metzner, MD PhD, Christoph Röllig, MD MSC, Bernd Hertenstein, Tobias Dechow, Wolfram Jung, MD, Helmut Ostermann, MD, Holger Hebart, Georg Maschmeyer, MD, Hans Jürgen Salwender, MD, Marie von Lilienfeld-Toal, MD, Kai-Uwe Eckardt, MD, Christian Straka, MD PhD, Hermann Einsele, MD, Stefan Knop
Journal: Blood
Blood (2019) 134 (Supplement_1): 1840.
https://doi.org/10.1182/blood-2019-125235
Published: 2019
Journal Articles

Full Dose or Reduced Dose Melphalan (MEL) for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): A Single Center Analysis on 187 Consecutive Patients

Annamaria Brioli, MD, vom Hofe Felix, Lars-Olof Mügge, MD, Sebastian Scholl, MD, Inken Hilgendorf, MD, Herbert G. Sayer, MD PhD, Olaposi Yomade, MD, Thomas Ernst, Andreas Hochhaus, MD, Marie von Lilienfeld-Toal, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4625.
https://doi.org/10.1182/blood-2018-99-112045
Published: 2018
Journal Articles

Induction with Bortezomib Melphalan and Prednisolon (VMP) Is Associated with Unexpectedly High Discontinuation Rate in Elderly Multiple Myeloma Patients: First Analysis of the German Maintenance (GERMAIN) Trial

Annamaria Brioli, MD, Kirsi Manz, Mathias Hänel, MD, Markus Pfirrmann, PhD, Andreas Christoph Schwarzer, MD, Marie von Lilienfeld-Toal, MD, Gabriele Prange-Krex, Christian Fabisch, PhD, Stefan Knop, Thomas Illmer, MD, Beate Krammer-Steiner, Andreas Hochhaus, MD, Lars-Olof Mügge, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2016.
https://doi.org/10.1182/blood-2018-99-115964
Published: 2018
Journal Articles

Lenalidomide, Adriamycin and Dexamethasone (RAD) Versus Bortezomib, Lenalidomide and Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) - Post-Induction Response and MRD Results By Flow Cytometry and NGS from a Phase 3 Randomized Controlled Clinical Trial (RCT)

Thomas Stübig, MD, Christian Langer, MD, Monika Engelhardt, MD, Lars-Olof Mügge, MD, Florian Bassermann, MD PhD, Martin Schreder, MD, Kerstin Schäfer-Eckart, MD, Igor Wolfgang Blau, Denise Wolleschak, Albrecht Reichle, MD, Ivana Metzler, MD, Bernd Metzner, MDPhD, Christoph Rollig, MD MSC, Bernd Hertenstein, MD, Heinz Dürk, Harald Biersack, MD, Helge Menzel, MD, Tobias Dechow, Jan Schleicher, Martin Gramatzki, MD, Tim H. Brümmendorf, MD, Stephan Fuhrmann, Max Bittrich, MD, Franziska Appelt, Martina Müller, Jan Krönke, MD, Julia Reusch, Christian Schmidt, MD, Monika Brüggemann, MD, Swantje Held, Stefan Knop, Hermann Einsele, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1979.
https://doi.org/10.1182/blood-2018-99-116067
Published: 2018
Journal Articles

Functional Geriatric Assessment (F-GA) in Multiple Myeloma Patients: Results from a Prospective Multicenter Study Group (DSMM) Trial and Changes from Baseline to Follow-up Assessment

Sophia Scheubeck, Sandra Maria Dold, M. Sc., Gabriele Ihorst, PhD, Alexander Zober, MD, Stefan J. Müller, Dipl.-Pharm., Christian Langer, MD, Wolfram Pönisch, Lars-Olof Mügge, MD, Stefan Knop, MD, Justus Duyster, MD, Martin Schumacher, PhD, Ralph M. Waesch, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2016) 128 (22): 5627.
https://doi.org/10.1182/blood.V128.22.5627.5627
Published: 2016
Journal Articles

Improved Safety with the Use of Subcutaneous Bortezomib in Combination with Panobinostat and Dexamethasone: Preliminary Data from a Panobinostat Global Expanded Treatment Protocol

Andreas Guenther, MD, Lars-Olof Mügge, Mathias Haenel, MD, Fredrik H. Schjesvold, MD, Daniel Lechner, Sameer Yaser, Holger Hebart, MD, Heinz Gisslinger, Richard Greil, MD, Eberhard Gunsilius, MD, Martin Goerner, MD, Katja Weisel, Jan Dürig, MD, Mohamed Elemary, MD MSc,PhD, Denise Wolleschak, Stefan A. Klein, MD, Markus Munder, MD, Alexander Kiani, Hareth Nahi, Christian Junghanss, MD, Valerie Campello-Iddison, MD, Ythier Deniau, Xiaoshu Feng, Hermann Einsele, MD
Journal: Blood
Blood (2016) 128 (22): 5692.
https://doi.org/10.1182/blood.V128.22.5692.5692
Published: 2016
Journal Articles

Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial

Nizar J Bahlis, MD, Alessandro Corso, Lars-Olof Mugge, Zhi-Xiang Shen, Pierre Desjardins, Anne-Marie Stoppa, MD, Olivier Decaux, Thierry De Revel, Miquel Granell, Gerald Marit, Hareth Nahi, Hilde Demuynck, Shang-Yi Huang, Supratik Basu, Troy H. Guthrie, Annette Ervin-Haynes, Nicolas Leupin, Jennifer Marek, Guang Chen, Thierry Facon
Journal: Blood
Blood (2014) 124 (21): 3458.
https://doi.org/10.1182/blood.V124.21.3458.3458
Published: 2014
Journal Articles

Third Autologous Salvage Transplant at Late Myeloma Relapse Is Associated with Favourable Overall Survival and Contributes to Improvement of Exhausted Bone Marrow Function

Susanne Strifler, MD, Inken Hilgendorf, MD, Martina Kleber, MD, Christoph Röllig, MD, Lars-Olof Mügge, MD, Maria-Veronica Teleanu, MD, Brigitte Kragl, MD, Hermann Einsele, MD, Stefan Knop, MD
Journal: Blood
Blood (2014) 124 (21): 3988.
https://doi.org/10.1182/blood.V124.21.3988.3988
Published: 2014
Journal Articles

Response to Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Newly Diagnosed Multiple Myeloma Is Independent of Cytogenetic Risk and Retained after Double Stem Cell Transplant

Stefan Knop, MD, Christian Langer, MD, Monika Engelhardt, MD, Lars-Olof Mügge, MD, Albrecht Reichle, Wolf Rösler, MD, Florian Bassermann, MD, Bernd Hertenstein, MD, Isrid Sturm, MD, Christoph Röllig, MD, Helmut Ostermann, MD, Kerstin Schäfer-Eckart, MD, Mark Ringhoffer, MD, Andreas Günther, Christian Junghanss, MD, Harald Biersack, MD, Susanne Strifler, MD, Andreas Bachinger, Hermann Einsele, MD, Ralf C. Bargou
Journal: Blood
Blood (2014) 124 (21): 177.
https://doi.org/10.1182/blood.V124.21.177.177
Published: 2014